Loading insider details...
Beta
Latest Form 4 (Jun 29, 2024): Grant/Award of 200,000 ARDS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 29, 2024 | Aridis Pharmaceuticals, Inc. (ARDS) | Grant/Award | 200,000 | n/a |
| Sep 19, 2023 | Aridis Pharmaceuticals, Inc. (ARDS) | Grant/Award | 15,000 | n/a |
| Jun 15, 2023 | Aridis Pharmaceuticals, Inc. (ARDS) | Exercise/Conversion | 5,000 | n/a |
| Dec 7, 2022 | Aridis Pharmaceuticals, Inc. (ARDS) | Grant/Award | 10,000 | n/a |
| Oct 5, 2021 | Aridis Pharmaceuticals, Inc. (ARDS) | Grant/Award | 9,400 | n/a |
| Jul 28, 2021 | Aridis Pharmaceuticals, Inc. (ARDS) | Purchase | 2,000 | $9.7K |